Infertility news | Breaking infertility news

News

Advertisers:

First Biologic Therapy Approved in Canada for Painful Inflammatory ...

...Remicade is indicated for reducing signs and symptoms, inducing clinical remission, inducing mucosal healing, and reducing or eliminating corticosteroid use in patients with moderately to severely active ulcerative colitis who have had an inadequate response to conventional therapy.

The approval makes Remicade the first biologic therapy approved to treat moderately to severely active UC in Canada, addressing an unmet medical need for patients who previously had limited treatment options.

"Since Remicade's approval for Crohn's disease in 2001, the gastroenterology community has been watching this therapy with great interest, hoping it would have the same benefits for those UC patients, who until now, faced surgery as their only option," commented Dr.

Brian Feagan, gastroenterologist and director at Robarts Clinical Trials, Robarts Research Institute Canada.

"The data generated by ACT 1 and 2, two relatively large clinical trials, provide compelling evidence of the efficacy of Remicade in patients with ac...